1. Giralt S, Kantarjian H, Talpaz M. Treatment of chronic myelogenous leukemia.Semin Oncol 1995;22: 396–404.
2. Pfeffer LMet al. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons.Cancer Res 1998;58: 2489–2499.
3. Weiss K. Safety profile of interferon-α therapy.Semin Oncol 1998;25(Suppl 1): 9–13.
4. Pestka S. The human interferon-α species and hybrid proteins.Semin Oncol 1997;24(Suppl 9): 4–17.
5. Platanias LC, Fish EN. Signaling pathways activated by interferons.Exp Hematol 1999;27: 1583–1592.